Eagle Pharmaceuticals, Inc. Operating Income
Eagle Pharmaceuticals, Inc. reported Operating Income of $10.30 million for the 3-month period ending 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2023-08-09
- Eagle Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2023-06-30 was $10.30M, a 367.73% increase year-over-year.
- Eagle Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2023-03-31 was $11.77M, a 80.32% decline year-over-year.
- Eagle Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2022-12-31 was $9.47M, a 60.47% increase year-over-year.
- Eagle Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2022-09-30 was $9.46M.
- Eagle Pharmaceuticals, Inc. operating income (loss) for fiscal 2022 was $80.96M, a 2823.80% increase from fiscal 2021.
- Eagle Pharmaceuticals, Inc. operating income (loss) for fiscal 2021 was $2.77M, a 91.60% decline from fiscal 2020.
- Eagle Pharmaceuticals, Inc. operating income (loss) for fiscal 2020 was $32.95M, a 51.06% increase from fiscal 2019.
- Eagle Pharmaceuticals, Inc. operating income (loss) for fiscal 2019 was $21.82M, a 40.42% decline from fiscal 2018.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|
| 2023-06-30 | $10.30M 10-Q/A · filed 2023-08-09 | $22.08M 10-Q/A · filed 2023-08-09 | $31.54M derived: sum of 3 quarters · filed 2023-08-09 | $41.01M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2023-03-31 | $11.77M 10-Q · filed 2023-05-09 | $21.24M derived: sum of 2 quarters · filed 2023-05-09 | $30.70M derived: sum of 3 quarters · filed 2023-05-09 | $32.90M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-12-31 | $9.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $18.93M derived: sum of 2 quarters · filed 2023-03-23 | $21.13M derived: sum of 3 quarters · filed 2023-08-09 | $80.96M 10-K · filed 2023-03-23 | |
| 2022-09-30 | $9.46M 10-Q · filed 2022-11-09 | $11.66M derived: sum of 2 quarters · filed 2023-08-09 | $71.49M 10-Q · filed 2022-11-09 | $77.39M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-06-30 | $2.20M 10-Q/A · filed 2023-08-09 | $62.03M 10-Q/A · filed 2023-08-09 | $67.93M derived: sum of 3 quarters · filed 2023-08-09 | $57.75M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $59.83M 10-Q · filed 2023-05-09 | $65.73M derived: sum of 2 quarters · filed 2023-05-09 | $55.55M derived: sum of 3 quarters · filed 2023-05-09 | $66.37M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$4.28M derived: sum of 2 quarters · filed 2023-03-23 | $6.54M derived: sum of 3 quarters · filed 2023-03-23 | $2.77M 10-K · filed 2023-03-23 | |
| 2021-09-30 | -$10.18M 10-Q · filed 2022-11-09 | $643.00K derived: sum of 2 quarters · filed 2022-11-09 | -$3.13M 10-Q · filed 2022-11-09 | $6.66M derived: sum of 4 quarters · filed 2023-03-23 | |
| 2021-06-30 | $10.82M 10-Q · filed 2022-08-09 | $7.05M 10-Q · filed 2022-08-09 | $16.84M derived: sum of 3 quarters · filed 2023-03-23 | $32.26M derived: sum of 4 quarters · filed 2023-03-23 | |
| 2021-03-31 | -$3.77M 10-Q · filed 2022-05-09 | $6.02M derived: sum of 2 quarters · filed 2023-03-23 | $21.44M derived: sum of 3 quarters · filed 2023-03-23 | $25.15M derived: sum of 4 quarters · filed 2023-03-23 | |
| 2020-12-31 | $9.79M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $25.21M derived: sum of 2 quarters · filed 2023-03-23 | $28.92M derived: sum of 3 quarters · filed 2023-03-23 | $32.95M 10-K · filed 2023-03-23 | |
| 2020-09-30 | $15.42M 10-Q · filed 2021-11-09 | $19.13M derived: sum of 2 quarters · filed 2021-11-09 | $23.16M 10-Q · filed 2021-11-09 | $26.06M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2020-06-30 | $3.71M 10-Q · filed 2021-08-09 | $7.74M 10-Q · filed 2021-08-09 | $10.64M derived: sum of 3 quarters · filed 2021-08-09 | $8.16M derived: sum of 4 quarters · filed 2021-08-09 | |
| 2020-03-31 | $4.04M 10-Q · filed 2021-05-10 | $6.93M derived: sum of 2 quarters · filed 2021-05-10 | $4.45M derived: sum of 3 quarters · filed 2021-05-10 | $13.68M derived: sum of 4 quarters · filed 2021-05-10 | |
| 2019-12-31 | $2.90M 10-K · filed 2020-03-02 | $413.00K derived: sum of 2 quarters · filed 2020-11-02 | $9.65M derived: sum of 3 quarters · filed 2020-11-02 | $21.82M 10-K · filed 2022-03-08 | |
| 2019-09-30 | -$2.48M 10-Q · filed 2020-11-02 | $6.75M derived: sum of 2 quarters · filed 2020-11-02 | $18.92M 10-Q · filed 2020-11-02 | $34.64M derived: sum of 4 quarters · filed 2020-11-02 | |
| 2019-06-30 | $9.23M 10-Q · filed 2020-08-10 | $21.40M 10-Q · filed 2020-08-10 | $37.13M derived: sum of 3 quarters · filed 2020-08-10 | $55.53M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $12.17M 10-Q · filed 2020-05-11 | $27.89M derived: sum of 2 quarters · filed 2020-05-11 | $46.30M derived: sum of 3 quarters · filed 2020-05-11 | $46.48M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | $15.73M 10-K · filed 2020-03-02 | $34.13M derived: sum of 2 quarters · filed 2020-03-02 | $34.31M derived: sum of 3 quarters · filed 2020-03-02 | $36.62M 10-K · filed 2021-03-05 | |
| 2018-09-30 | $18.40M 10-K · filed 2020-03-02 | $18.59M derived: sum of 2 quarters · filed 2020-03-02 | $20.89M 10-Q · filed 2019-11-12 | $31.33M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | $183.00K 10-K · filed 2020-03-02 | $2.49M 10-Q · filed 2019-08-08 | $12.93M derived: sum of 3 quarters · filed 2020-03-02 | $37.88M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | $2.31M 10-K · filed 2020-03-02 | $12.75M derived: sum of 2 quarters · filed 2020-03-02 | $37.70M derived: sum of 3 quarters · filed 2020-03-02 | $43.60M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | $10.44M 10-K · filed 2019-02-28 | $35.39M derived: sum of 2 quarters · filed 2019-02-28 | $41.29M derived: sum of 3 quarters · filed 2019-02-28 | $73.99M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $24.95M 10-K · filed 2019-02-28 | $30.85M derived: sum of 2 quarters · filed 2019-02-28 | $63.55M 10-Q · filed 2018-11-01 | $91.83M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-06-30 | $5.90M 10-K · filed 2019-02-28 | $38.60M 10-Q · filed 2018-08-07 | $66.88M derived: sum of 3 quarters · filed 2019-02-28 | $79.19M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-03-31 | $32.70M 10-K · filed 2019-02-28 | $60.98M derived: sum of 2 quarters · filed 2019-02-28 | $73.29M derived: sum of 3 quarters · filed 2019-02-28 | $86.94M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2016-12-31 | $28.28M 10-K · filed 2018-02-26 | $40.59M derived: sum of 2 quarters · filed 2018-02-26 | $54.25M derived: sum of 3 quarters · filed 2018-02-26 | $53.35M 10-K · filed 2019-02-28 | |
| 2016-09-30 | $12.31M 10-K · filed 2018-02-26 | $25.96M derived: sum of 2 quarters · filed 2018-02-26 | $25.07M 10-Q · filed 2017-11-08 | $26.26M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2016-06-30 | $13.66M 10-K · filed 2018-02-26 | $12.76M 10-Q · filed 2017-08-09 | $13.95M derived: sum of 3 quarters · filed 2018-02-26 | $3.56M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2016-03-31 | -$897.00K 10-K · filed 2018-02-26 | $296.00K derived: sum of 2 quarters · filed 2018-02-26 | -$10.09M derived: sum of 3 quarters · filed 2018-02-26 | -$18.43M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2015-12-31 | $1.19M 10-K · filed 2017-03-15 | -$9.20M derived: sum of 2 quarters · filed 2017-03-15 | -$17.53M derived: sum of 3 quarters · filed 2017-03-15 | $2.56M 10-K · filed 2018-02-26 | |
| 2015-09-30 | -$10.39M 10-K · filed 2017-03-15 | -$18.72M derived: sum of 2 quarters · filed 2017-03-15 | $1.37M 10-Q · filed 2016-11-09 | -$5.20M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2015-06-30 | -$8.34M 10-K · filed 2017-03-15 | $11.76M 10-Q · filed 2016-08-09 | $5.19M derived: sum of 3 quarters · filed 2017-03-15 | -$3.92M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2015-03-31 | $20.09M 10-K · filed 2017-03-15 | $13.53M derived: sum of 2 quarters · filed 2017-03-15 | $4.42M derived: sum of 3 quarters · filed 2017-03-15 | $1.44M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2014-12-31 | -$6.57M 10-K · filed 2017-03-15 | -$15.67M derived: sum of 2 quarters · filed 2017-03-15 | -$18.65M derived: sum of 3 quarters · filed 2017-03-15 | -$22.26M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2014-09-30 | -$9.11M 10-K · filed 2016-02-29 | -$9.11M 10-Q · filed 2015-11-12 | -$12.09M derived: sum of 2 quarters · filed 2016-02-29 | -$15.69M 10-Q · filed 2015-11-12 | -$18.76M 10-K · filed 2017-03-15 |
| 2014-06-30 | -$2.98M 10-K · filed 2016-02-29 | -$2.98M 10-Q · filed 2014-08-11 | -$6.59M 10-Q · filed 2015-08-11 | -$9.65M 10-Q · filed 2014-08-11 | -$12.18M derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-03-31 | -$3.60M 10-K · filed 2016-02-29 | -$3.60M 10-Q · filed 2014-05-15 | -$6.67M 10-Q · filed 2014-05-15 | -$9.20M derived: sum of 3 quarters · filed 2017-03-15 | -$7.94M derived: sum of 4 quarters · filed 2017-03-15 |
| 2013-12-31 | -$3.06M 10-K · filed 2017-03-15 | -$5.60M derived: sum of 2 quarters · filed 2017-03-15 | -$4.34M derived: sum of 3 quarters · filed 2017-03-15 | -$8.64M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2013-09-30 | -$2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$1.27M derived: sum of 2 quarters · filed 2016-02-29 | -$5.58M derived: sum of 3 quarters · filed 2016-02-29 | -$8.46M 10-K · filed 2016-02-29 | |
| 2013-06-30 | $1.26M 10-Q · filed 2014-08-11 | -$3.05M derived: sum of 2 quarters · filed 2014-08-11 | -$5.92M 10-Q · filed 2014-08-11 | ||
| 2013-03-31 | -$4.31M 10-Q · filed 2014-05-15 | -$7.18M 10-Q · filed 2014-05-15 | |||
| 2012-09-30 | -$19.83M 10-K · filed 2014-12-22 |